Xu, Lingfan http://orcid.org/0000-0003-2465-241X
Zhao, Bing
Butler, William
Xu, Huan
Song, Nan
Chen, Xufeng
Spencer Hauck, J.
Gao, Xia
Zhang, Hong
Groth, Jeff
Yang, Qing
Zhao, Yue
Moon, David
George, Daniel
Zhou, Yinglu
He, Yiping
Huang, Jiaoti http://orcid.org/0000-0003-1195-1998
Funding for this research was provided by:
U.S. Department of Defense (DOD-W81XWH-19-1-0411, W81XWH2110034)
Prostate Cancer Foundation (Movember Valor Challenge Award)
U.S. Department of Health & Human Services | National Institutes of Health (K99-K99CA237618)
Article History
Received: 17 July 2021
Revised: 1 December 2021
Accepted: 13 December 2021
First Online: 20 January 2022
Competing interests
: JH is a consultant for or owns shares in the following companies: Kingmed, MoreHealth, OptraScan, Genetron, Omnitura, Vetonco, York Biotechnology, Genecode, VIVA Biotechnology and Sisu Pharma.